NZpharma
Timeline
8 events since 2023Filings
Financial
Establishments
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 41 days late
2025
Liquidity more than triples current ratio 7.13 The current ratio rises from 2.11 to 7.13. Short-term debt falls from €28,013 to €9,203.
Registered in the Peppol Directory Reachable for e-invoices through 0208:1002404928
Annual accounts 2024 filed PDFmicro format · 60 days late
2024
Highest result from 2023 to 2025 net €33,434 ▲614% The operating result of €43,352 and the net result of €33,434 are both a record.
Annual accounts 2023 filed PDFmicro format · 153 days late
2023
IncorporationFounder: Nzouakeu Tankoua Stella Morelle · 1,000 shares · Appointment: Nzouakeu Tankoua Stella Morelle (director) · published on 21-11-20234 points ▸
- Founder, Nzouakeu Tankoua Stella Morelle
- 1,000 shares, mentioned twice in the deed
- Registered office clause, Woluwe-Saint-Lambert (1200 Bruxelles), Avenue Marcel Thiry 204
- Director appointment, Nzouakeu Tankoua Stella Morelle (director (not named in the articles))
- The deed holds 1 more point.
First establishment Marcel Thirylaan 204, Woluwe-Saint-Lambert
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 17 November 2023, NZpharma was incorporated as a private limited company by one natural person.12 Nzouakeu Tankoua Stella Morelle has served as director since 2023.3 Total assets went from €19,246 in 2023 to €74,203 in 2025.4